Literature DB >> 20081364

Yin Yang 1 overexpression in diffuse large B-cell lymphoma is associated with B-cell transformation and tumor progression.

Giancarlo Castellano1, Elena Torrisi, Giovanni Ligresti, Ferdinando Nicoletti, Grazia Malaponte, Salvatore Traval, James A McCubrey, Silvana Canevari, Massimo Libra.   

Abstract

Yin Yang 1 (YY1), a multifunctional transcription factor, has been shown to be involved in the pathogenesis of several cancer types. However, its role in hematological malignancies has not yet been fully investigated. In the present study, using computational methods, we showed that YY1 transcript levels were significantly increased in the high-grade lymphomas, including Burkitt's lymphoma and diffuse large B-cell lymphoma (DLBCL), compared with those of both low-grade lymphomas and normal B-cells. The significant increase in gene expression resulted in a significant increase also at protein level in three NHL cell lines. The association of YY1 expression with some clinical-pathological features in DLBCL showed a positive correlation between a high level of YY1 mRNA and high levels of BCL-6 protein. Moreover, by analyzing the large series of DLBCL in the Hummel dataset, we identified the transcription factor PAX-5 among the top 50 genes positively correlated with YY1. These findings are also supported by the biological network analysis in which the top network, with the highest score, associated with YY1 expression levels in DLBCL is cellular movement, hematological system development and function, and immune response. overall these data suggest that YY1 is involved in B cells transformation which gives rise to high-grade lymphomas through a dysregulation in the normal development of B cells affecting cell cycle and cellular motility.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20081364     DOI: 10.4161/cc.9.3.10554

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  30 in total

Review 1.  Mechanisms of Yin Yang 1 in oncogenesis: the importance of indirect effects.

Authors:  Michael Atchison; Arindam Basu; Kristina Zaprazna; Madhusudhan Papasani
Journal:  Crit Rev Oncog       Date:  2011

Review 2.  The oncogenic role of Yin Yang 1.

Authors:  Qiang Zhang; Daniel B Stovall; Kazushi Inoue; Guangchao Sui
Journal:  Crit Rev Oncog       Date:  2011

Review 3.  Neomorphic mutations create therapeutic challenges in cancer.

Authors:  V Takiar; C K M Ip; M Gao; G B Mills; L W T Cheung
Journal:  Oncogene       Date:  2016-11-14       Impact factor: 9.867

4.  YY1 controls immunoglobulin class switch recombination and nuclear activation-induced deaminase levels.

Authors:  Kristina Zaprazna; Michael L Atchison
Journal:  Mol Cell Biol       Date:  2012-01-30       Impact factor: 4.272

5.  Gene set enrichment analysis of the NF-κB/Snail/YY1/RKIP circuitry in multiple myeloma.

Authors:  Apostolos Zaravinos; Peggy Kanellou; George I Lambrou; Demetrios A Spandidos
Journal:  Tumour Biol       Date:  2014-01-31

6.  Expression of YY1 in Differentiated Thyroid Cancer.

Authors:  Jéssica Arribas; Josep Castellví; Ricard Marcos; Carles Zafón; Antonia Velázquez
Journal:  Endocr Pathol       Date:  2015-05       Impact factor: 3.943

7.  YY1 Regulates the Germinal Center Reaction by Inhibiting Apoptosis.

Authors:  Sally E Trabucco; Rachel M Gerstein; Hong Zhang
Journal:  J Immunol       Date:  2016-07-22       Impact factor: 5.422

8.  Deficiency of Wiskott-Aldrich syndrome protein has opposing effect on the pro-oncogenic pathway activation in nonmalignant versus malignant lymphocytes.

Authors:  Seong-Su Han; Kuo-Kuang Wen; Yatin M Vyas
Journal:  Oncogene       Date:  2020-11-02       Impact factor: 9.867

Review 9.  The Role of Transcription Factor YY1 in the Biology of Cancer.

Authors:  Neeraj Agarwal; Dan Theodorescu
Journal:  Crit Rev Oncog       Date:  2017

10.  Nectin like-5 overexpression correlates with the malignant phenotype in cutaneous melanoma.

Authors:  Valentina Bevelacqua; Ylenia Bevelacqua; Saverio Candido; Evangelia Skarmoutsou; Alfredo Amoroso; Claudio Guarneri; Angela Strazzanti; Pietro Gangemi; Maria C Mazzarino; Fabio D'Amico; James A McCubrey; Massimo Libra; Grazia Malaponte
Journal:  Oncotarget       Date:  2012-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.